Kazuo Ikeda

Kazuo Ikeda

Auto-generated profile, based on publicly available information

Kazuo Ikeda

Osaka Metropolitan University

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Science Advances
Verified
Journal Article
Open access
THTruong Huu Hoang
Truong Huu Hoang
MSMisako Sato-Matsubara
Misako Sato-Matsubara
HYHideto Yuasa
Hideto Yuasa
TMTsutomu Matsubara
Tsutomu Matsubara
LTLe Thi Thanh Thuy
Le Thi Thanh Thuy
NKNorifumi Kawada
Norifumi Kawada
Intracellular gap (iGap) formation in liver sinusoidal endothelial cells (LSECs) is caused by the destruction of fenestrae and appears under pathological conditions; nevertheless, their role in metastasis of cancer cells to the liver remained unexplored. We elucidated that hepatotoxin-damaged and fibrotic livers gave rise to LSECs-iGap formation, which was positively correlated with increased numbers of metastatic liver foci after intrasplenic injection of Hepa1-6 cells. Hepa1-6 cells induced interleukin-23–dependent tumor necrosis factor–α (TNF-α) secretion by LSECs and triggered LSECs-iGap formation, toward which their processes protruded to transmigrate into the liver parenchyma. TNF-α triggered depolymerization of F-actin and induced matrix metalloproteinase 9 (MMP9), intracellular adhesion molecule 1, and CXCL expression in LSECs. Blocking MMP9 activity by doxycycline or an MMP2/9 inhibitor eliminated LSECs-iGap formation and attenuated liver metastasis of Hepa1-6 cells. Overall, this study revealed that cancer cells induced LSEC-iGap formation via proinflammatory paracrine mechanisms and proposed MMP9 as a favorable target for blocking cancer cell metastasis to the liver.

1 April 2010 in Journal of Dermatological Science
Verified
Journal Article
Open access
PDF file
HIHisayoshi Imanishi
Hisayoshi Imanishi
Daisuke TsurutaDaisuke Tsuruta
Daisuke Tsuruta
CTChiharu Tateishi
Chiharu Tateishi
KSKoji Sugawara
Koji Sugawara
RPRalf Paus
Ralf Paus
HKHiromi Kobayashi
Hiromi Kobayashi
Background Chemotherapy-induced alopecia (CIA) has a devastating cosmetic effect, especially in the young. Recent data indicate that two major basement membrane components (laminin-332 and -511) of the skin have opposing effects on hair growth. Objective In this study, we examined the role and localization of laminin-332 and -511 in CIA. Methods We examined the expression of laminin-332 and -511 during the dystrophic catagen form of CIA induced in C57BL/6 mice by cyclophosphamide (CYP) treatment. Results Our data indicate that both laminin-332 and its receptor α6β4 integrin are up-regulated (both quantitatively and spatially) after mid to late dystrophic catagen around the outer root sheath (ORS) in the lower third of hair follicles in CIA. This up-regulation also occurs at the transcriptional level. In contrast, laminin-511 is down-regulated after mid dystrophic catagen at the protein level, with transcriptional inactivation of laminin-511 occurring transiently at the early dystrophic catagen stage in both epidermal and ORS keratinocytes. Laminin-511 expression correlates with expression of α3 integrin in CIA and we also demonstrate that laminin-511 can up-regulate the activity of the α3 integrin promoter in cultured keratinocytes. Injection of a laminin-511 rich protein extract, but not recombinant laminin-332, in the back skin of mice delays hair loss in CYP-induced CIA. Conclusions We propose that abrupt hair loss in CIA is, at least in part, caused by down-regulation of laminin-511 and up-regulation of laminin-332 at the transcriptional and translational levels.

1 August 2010 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
KIKazuo Ikeda
Kazuo Ikeda
NONaoki Osamura
Naoki Osamura

1 October 2000 in British Journal of Surgery
Verified
Journal Article
Closed access
SYS Yachida
S Yachida
KIK Ikeda
K Ikeda
KKK Kaneda
K Kaneda
FGF Goda
F Goda
TMT Maeba
T Maeba
HMH Maeta
H Maeta

1 March 2023 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Closed access
HUHayato Urushima
Hayato Urushima
TMTsutomu Matsubara
Tsutomu Matsubara
MMMasaaki Miyakoshi
Masaaki Miyakoshi
SKShioko Kimura
Shioko Kimura
HYHideto Yuasa
Hideto Yuasa
KIKazuo Ikeda
Kazuo Ikeda
Our study first revealed that hypo-osmolarity-induced mechanotransduction enhanced calcium-mediated AKT signaling via TRPV2 activation, resulting in contributing to apoptosis resistance. The finding indicates a possible view that liver cirrhosis-induced hyponatremia promotes hepatocellular carcinogenesis.

1 December 2024 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Open access
HUHayato Urushima
Hayato Urushima
TMTsutomu Matsubara
Tsutomu Matsubara
GQGu Qiongya
Gu Qiongya
ADAtsuko Daikoku
Atsuko Daikoku
MTMisako Takayama
Misako Takayama
KIKazuo Ikeda
Kazuo Ikeda
AHCC, a standardized extract of cultured Lentinula edodes mycelia, suppresses liver fibrosis progression by induction of cytoglobin via the Toll-like receptor 2 (TLR2)-stress-activated protein kinase/Jun NH2-terminal kinase (SAPK/JNK) pathway and the inhibition of collagen production via the TLR4-NFκβ pathway in hepatic stellate cells. Daily oral administration of AHCC from the stage of MASLD may have the potential to prevent disease progression to MASH with fibrosis.